| __timestamp | Biogen Inc. | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 2232342000 | 38783000000 |
| Thursday, January 1, 2015 | 2113100000 | 42585000000 |
| Friday, January 1, 2016 | 1947900000 | 45702000000 |
| Sunday, January 1, 2017 | 1935500000 | 46372000000 |
| Monday, January 1, 2018 | 2106300000 | 46910000000 |
| Tuesday, January 1, 2019 | 2374700000 | 48890000000 |
| Wednesday, January 1, 2020 | 2504500000 | 50129000000 |
| Friday, January 1, 2021 | 2674300000 | 54559000000 |
| Saturday, January 1, 2022 | 2403600000 | 62081000000 |
| Sunday, January 1, 2023 | 2549700000 | 105931000000 |
| Monday, January 1, 2024 | 2403700000 | 77201000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of major players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Biogen Inc. and Dr. Reddy's Laboratories Limited from 2014 to 2023. Over this period, Dr. Reddy's Laboratories consistently outpaced Biogen, with SG&A expenses peaking at over $105 billion in 2023, a staggering 300% increase from 2014. In contrast, Biogen's expenses showed a more modest growth, peaking at approximately $2.67 billion in 2021, reflecting a 20% increase from 2014. This disparity highlights the differing strategic priorities and market challenges faced by these companies. Notably, the data for 2024 is incomplete, indicating potential shifts in future trends. As the pharmaceutical landscape continues to change, these insights provide a window into the operational strategies of these industry leaders.
Breaking Down SG&A Expenses: AstraZeneca PLC vs Biogen Inc.
Selling, General, and Administrative Costs: Sanofi vs Dr. Reddy's Laboratories Limited
Who Optimizes SG&A Costs Better? Bristol-Myers Squibb Company or Biogen Inc.
Selling, General, and Administrative Costs: argenx SE vs Biogen Inc.
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Dr. Reddy's Laboratories Limited
Cost Management Insights: SG&A Expenses for Biogen Inc. and Corcept Therapeutics Incorporated
Selling, General, and Administrative Costs: Biogen Inc. vs Wave Life Sciences Ltd.
SG&A Efficiency Analysis: Comparing Biogen Inc. and Ligand Pharmaceuticals Incorporated
Intra-Cellular Therapies, Inc. and Dr. Reddy's Laboratories Limited: SG&A Spending Patterns Compared
Dr. Reddy's Laboratories Limited vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and TG Therapeutics, Inc.
Dr. Reddy's Laboratories Limited and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared